• The Daily Trade
  • Posts
  • Market Moves: Profit-Taking and Election Aftermath Shake Up Stocks

Market Moves: Profit-Taking and Election Aftermath Shake Up Stocks

The Daily Trade delivers sharp, daily insights on the US stock market.

Start your day with a quick look at top market news, then dive into our technical analysis of over 10,000 stocks to uncover overbought and oversold opportunities.

Stay informed, spot trends, and trade with confidence— no fluff, just actionable intel.

Profit-taking trims post-election gains (5 minute read)
After a 5% gain in the S&P 500 Index, traders engaged in profit-taking amid concerns about the sustainability of recent market optimism, particularly regarding small-cap stocks and the impact of tariffs on the economy. Meanwhile, semiconductor stocks faced selling pressure due to disappointing earnings guidance, and the strengthening dollar, coupled with rising interest rates, negatively affected precious metals and commodities, leading to predictions of increased volatility in the market ahead.


AP Business SummaryBrief (6 minute read)
In October, U.S. retail sales increased by 0.4%, driven by significant gains in auto sales and electronics, indicating strong consumer spending ahead of the holiday season. Meanwhile, the stock market experienced a notable decline, attributed to fading investor optimism following Donald Trump's election and concerns over vaccine manufacturers.


Archegos' Bill Hwang deserves 21 years in prison, US says (3 minute read)
Bill Hwang, founder of Archegos Capital Management, faces a 21-year prison sentence for a market manipulation scheme that resulted in the collapse of his $36 billion firm and over $10 billion in losses for lenders. Prosecutors described him as an "unrepentant recidivist," citing his previous guilty plea to wire fraud, and are also seeking a $12.35 billion forfeiture and restitution for victims.


"Trump Trade" Sends Investors Into Overdrive (11 minute read)
Following the recent election and interest rate cuts by the Federal Reserve, the market surged, reaching a year-end target of 6000, but is currently experiencing some overbought conditions and profit-taking. While optimism remains for continued growth due to the "Trump Trade," caution is advised as risks related to economic conditions and elevated valuations may impact future earnings growth.


Nvidia's Report Poised To Shape Tech And AI Markets (2 minute read)
Nvidia Corp is set to release its quarterly earnings report on November 20, which is anticipated to significantly impact the US stock market, particularly in the tech and AI sectors. With expectations of a net income of $18.4 billion and an 80% revenue increase, Nvidia's performance will be crucial for investor confidence and could influence broader market behavior amid economic uncertainties and high S&P 500 valuations.




Technical Analysis Results

Overvalued
BE
Bloom Energy Corporation
Volume: 64.7M shares | Price: $21.14

30 Day Performance
30-Day Price History

Technical Indicator Score: 100% Sell
Out of the 8 technical indicators that were used to analyze this stock, 8 indicated sell signals.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Sell
ULTOSC
Sell
STOCH
Sell

Recent Mentions of BE

Bloom Energy Corporation (BE) Secures Landmark 1 GW Fuel Cell Supply Agreement with American Electric Power to Power AI Data Centers
We recently compiled a list of the 10 AI News Making Waves Today. In this article, we are going to take a look at where Bloom Energy Corporation (NYSE:BE) stands against the other AI stocks that are making waves today. Is the AGI bubble about to burst? According to Margaret Mitchell, chief ethics scientist at the […]

Bloom Energy stock soars on American Electric Power deal
Bloom Energy (BE) stock rallied Friday afternoon after the company announced a new deal with American Electric Power (AEP). Under the agreement, AEP will use Bloom's fuel cell technology to provide power solutions for artificial intelligence data centers. Market Domination Hosts Julie Hyman and Josh Lipton break down the details. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith




Undervalued
KO
Coca-Cola Company
Volume: 25.2M shares | Price: $61.74

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of KO

How NASCAR’s $7.7 billion media rights deal aims to modernize sport
NASCAR signed a historic media rights extension last year worth $7.7 billion over seven years. The deal provides inventory to four broadcasters who will split 38 races across their channels each year starting with the 2025 season.

Should You Forget Coca-Cola? Why These Unstoppable Stocks Are Better Buys.
There's nothing wrong with Coca-Cola (NYSE: KO) as a company. Coke's biggest strength is that it is a dominant beverage maker. At the end of the day, beverages are just one tiny niche of the broader consumer staples sector.




Undervalued
PFE
Pfizer Inc.
Volume: 124.8M shares | Price: $24.80

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Buy

Recent Mentions of PFE

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded companies.

Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS
Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and Human Services.




Undervalued
LINE
Lineage, Inc. Common Stock
Volume: 1.8M shares | Price: $63.53

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of LINE

Decoding Lineage Inc (LINE): A Strategic SWOT Insight
Unraveling the Financial Fabric and Strategic Directions of Lineage Inc

Lineage, Inc. Reports Third-Quarter 2024 Financial Results
NOVI, Mich., November 06, 2024--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world’s largest global temperature-controlled warehouse REIT, today announced its financial results for the third quarter of 2024.




Undervalued
SWK
Stanley Black & Decker, Inc.
Volume: 1.5M shares | Price: $85.45

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of SWK

Is Stanley Black & Decker, Inc. (NYSE:SWK) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Stanley Black & Decker fair value estimate is US$158 Stanley...

Stanley Black and Decker Expects $200M Hit from Tariff Hikes
The tool maker is "preparing to discuss potential price increases."




Undervalued
CAG
Conagra Brands, Inc.
Volume: 10.5M shares | Price: $26.70

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Buy

Recent Mentions of CAG

Conagra Brands Named to Military Times' 2024 Best for Vets: Employers List
Conagra Brands, Inc. (NYSE: CAG) today announced that it has been recognized on the 2024 Best for Vets: Employers list by Military Times. This recognition comes as the company continues to demonstrate its dedication to supporting veterans and active-duty service members, as well as their families, through strategic partnerships and internal initiatives.

Conagra Brands, Inc. (NYSE:CAG) down to US$13b market cap, but institutional owners may not be as affected after a year of 3.5% returns
Key Insights Given the large stake in the stock by institutions, Conagra Brands' stock price might be vulnerable to...




Undervalued
NSIT
Insight Enterprises Inc
Volume: 460.6K shares | Price: $151.50

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of NSIT

We Think Insight Enterprises' (NASDAQ:NSIT) Solid Earnings Are Understated
The stock was sluggish on the back of Insight Enterprises, Inc.'s ( NASDAQ:NSIT ) recent earnings report. Along with...

Insight Unveils State-of-the-Art Solutions Integration Center in Fort Worth, Texas
CHANDLER, Ariz., November 06, 2024--Insight Enterprises (NASDAQ:NSIT) held the grand opening today in Fort Worth, Texas, of its latest Solutions Integration Center. The 250,000-square-foot facility serves clients across the United States and is powered by the latest technology, making it a paragon of modern warehouse operations. With AI-driven capabilities like autonomous mobile robotics and advanced logistics, it can achieve 10 times the shipping velocity of traditional IT fulfillment centers.




Overvalued
DIS
The Walt Disney Company
Volume: 31.4M shares | Price: $115.08

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Sell
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated sell signals, 1 indicated a neutral signal.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Hold
CCI
Sell
BBANDS
Sell
ULTOSC
Sell
STOCH
Sell

Recent Mentions of DIS

Analysts review Disney stock price targets after earnings
This is what could happen next to Disney shares.

Insiders Of Walt Disney Are Up 17% On Their US$3.22m Purchase
The Walt Disney Company ( NYSE:DIS ) insiders who purchased shares in the last 12 months were richly rewarded last...




Overvalued
BILL
BILL Holdings, Inc.
Volume: 2.6M shares | Price: $84.69

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Sell
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated sell signals, 1 indicated a neutral signal.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Hold
ULTOSC
Sell
STOCH
Sell

Recent Mentions of BILL

1 No-Brainer Growth Stock to Buy With $500 and Hold for the Long Run
This software company has barely scratched the surface of its enormous addressable market.

BILL Holdings First Quarter 2025 Earnings: Beats Expectations
BILL Holdings ( NYSE:BILL ) First Quarter 2025 Results Key Financial Results Revenue: US$358.5m (up 18% from 1Q 2024...




Undervalued
MRK
Merck & Co., Inc.
Volume: 15.9M shares | Price: $96.31

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Buy

Recent Mentions of MRK

How analysts are reacting to RFK Jr. as Trump's HHS pick
President-elect Donald Trump has selected Robert F. Kennedy Jr. for the position of Secretary of Health & Human Services (HHS). The appointment has drawn significant attention due to Kennedy Jr.'s controversial stance on vaccines, including his designation as one of the "Disinformation Dozen" during the COVID-19 pandemic. Following the announcement, vaccine-related stocks experienced a notable decline. Yahoo Finance Senior Health Reporter Anjalee Khemlani analyzes the implications of this appointment and shares reactions from market analysts regarding its potential impact on the healthcare sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
MRK in-licenses a bispecific antibody, based on the same mechanism as SMMT's lead drug, which outperformed its blockbuster drug, Keytruda, in a lung cancer study.




We want to hear from YOU!

Technical indicator analysis feedback request

Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.

Simply reply to this email with your thoughts. Every comment helps us serve you better.

Thank you for being a valued reader.

How would you rate today's newsletter?

If there's anything I can do better, please let me know so I can make improvements!

Login or Subscribe to participate in polls.

Technical Indicator Information

Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30

Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20

Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80

Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75

Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal

Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20

Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100

Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band

Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price

Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0

Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30

Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI

Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25

Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.

Disclaimers

The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.

Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.

The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.